市場調査レポート
商品コード
1439440
デジタル/電気血圧計 - 世界市場の考察、競合情勢、市場予測(2030年)Digital/Electrical Sphygmomanometer - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
デジタル/電気血圧計 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界のデジタル/電気血圧計の市場規模は、2023年に9億7,778万米ドル、2030年までに17億8,388万米ドルに達し、2024年~2030年の予測期間にCAGRで10.57%の成長が見込まれます。市場は、高血圧などの血液関連疾患の症例の増加、製品開発における急速な進化と技術の進歩、高血圧のリスクにさらされやすい老年人口の増加などの要因により、前向きな市場成長を示しています。
デジタル/電気血圧計の市場力学
デジタル/電気血圧計市場の主な促進要因の1つは、高血圧などの血液関連疾患の症例の増加です。WHO(2022)の最新のデータによると、現在、30~79歳の成人約12億8,000万人が世界中で高血圧症に罹患しており、患者人口の大部分(3分の2)は中低所得国にいます。血圧の上昇は診断の増加と関連しており、血液関連疾患や心血管疾患の有病率がますます高まることが立証されています。このことは最終的に、時間の経過とともにデジタル/電気血圧計の市場成長の進行に寄与します。
さらに、世界保健機関(WHO)が提供するデータによると、心血管疾患(CVD)は世界全体の主要死因であり、この疾患群が毎年推定1,790万人の命を奪っています。
さらに、European Society for Cardiology(ESC)のデータによると、毎年、欧州では心血管疾患(CVD)が390万人の死因となっており、欧州連合(EU)では180万人以上が死亡しています。CVDによる死亡者数は、欧州では全死亡者数の約45%、EUでは37%を占めています。したがって、デジタル/電気血圧計の需要は、CVDのような血液関連疾患の有病率の増加に起因する高成長を示す見込みであり、したがって予測期間(2024年~2030年)にデジタル/電気血圧計市場の成長にプラスの影響を与えます。
デジタル/電気血圧計市場の成長をもたらすもう1つの主な要因は、世界中での老年人口の増加です。世界保健機関(WHO)が提供したデータによると、2020年に世界中で約10億人が60歳以上となっています。さらに、2050年までに60歳以上の老年人口は倍増し、約21億人に達すると予測され、80歳以上の老年人口は2020年~2050年に3倍になり、4億2,600万人に達すると推定されています。老年人口は高血圧を発症しやすく、それが最終的にCVDやその他の疾患の発症につながるため、老年人口の増加は世界中の心血管疾患の患者数の増加につながると予測され、そのことが予測期間(2024年~2030年)におけるデジタル/電気血圧計の需要の増加につながり、デジタル/電気血圧計市場の成長を促進する可能性があります。
上記の要因とともに、歩留まりや診断精度を高める新技術の開発など、デジタル/電気血圧計の分野における技術の進歩もデジタル/電気血圧計市場の成長を後押しすると予測されます。例えば、2022年1月、Aktiaは米国の主要高血圧センターと共同で、その他の血圧モニターの100倍以上のデータを自動的に収集し、10倍以上のエンゲージメントを持つその世界の24時間稼働の血圧モニターについて、米国での画期的な高血圧試験を発表しました。
しかし、デバイスの高いコストや、デジタル/電気血圧計が非常に敏感であるために体の動きが精度に影響すること、または一部のデバイスが左腕でしか動作しないことなどの特定の要因が、この市場の成長を抑制すると予測されます。さらに、デバイスの継続的な再校正の必要性は、デジタル/電気血圧計市場成長の一定の抑制要因となる可能性があります。
デジタル/電気血圧計市場のセグメント分析
デジタル/電気血圧計市場の製品タイプセグメントでは、ポータブルデジタル/電気血圧計が予測期間(2024年~2030年)にデジタル/電気血圧計市場で大きなシェアを占めると予測されています。これは、これらのデバイスに関連する特定の機能によるものと考えられます。この製品セグメントの急成長は、早期の正確な診断に対する需要の高まりに起因すると考えられ、これらのデバイスの高い採用につながります。さらに、世界中の病院や在宅医療部門でポータブルデジタル/電気血圧計の採用が拡大していることも、市場成長を後押ししています。
当レポートでは、世界のデジタル/電気血圧計市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Digital/Electrical Sphygmomanometer Market By Product Type (Upper Arm, Wrist Type), By Technology (Full-Automatic, Semi-Automatic), By Portability (Portable, Non-Portable), By End-User (Hospitals And Clinics, Ambulatory Care Centers, Home Care Settings, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising cases of blood-related disorders and rapid evolution of advanced devices
The Global Digital/Electrical Sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030. The Digital/Electrical Sphygmomanometer market is witnessing a positive market growth owing to the factors such as the rising cases of blood-related disorders like high blood pressure and hypertension, rapid evolution and technological advancements in product development, increasing aging population who are more prone to hypertension risk.
Digital/Electrical Sphygmomanometer Market Dynamics:
One of the main drivers of the Digital/Electrical Sphygmomanometer market is the rising cases of blood-related disorders such as hypertension. As per the latest data provided by the WHO, 2022, approximately 1.28 billion adults in the 30-79 year age group are currently living with hypertension globally with the majority of the patient population (two-thirds) present in the low and middle-income countries. It has been established that increased blood pressure has been associated with the increased diagnosis which will lead to more and more prevalence of blood-related or cardiovascular diseases. This ultimately will contribute to the Digital/Electrical Sphygmomanometer market growth progression over time.
Moreover, as per the data provided by the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein this group of disease-account for an estimated 17.9 million lives each year.
Moreover, according to the data provided by the European Society for Cardiology (ESC), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU. Therefore, the demand for Digital/Electrical Sphygmomanometer is set to witness an increased growth owing to the increasing prevalence of blood-related disorders like CVDs, thereby positively impacting the Digital/Electrical Sphygmomanometer market growth during the forecast period (2024-2030).
Another key factor responsible for the growth of the Digital/Electrical Sphygmomanometer market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. The elderly population is more prone to developing high blood pressure which is ultimately associated with developing CVDs or other diseases, therefore, the rising elderly population is expected to lead to the rise in the patient population of cardiovascular diseases across the world, which in turn would lead to an increase in demand for Digital/Electrical Sphygmomanometer in the forecast period (2024-2030), which will drive the Digital/Electrical Sphygmomanometer market growth.
Along with the factors mentioned above, technological advancements in the field of Digital/Electrical Sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the Digital/Electrical Sphygmomanometer market. For instance, in January 2022, Aktiia announced a landmark hypertension trial in the United States in collaboration with a top US hypertension center, for its world's 24/7 blood pressure monitor, which automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.
However, certain factors like the high cost of devices and Digital/Electrical Sphygmomanometer being very sensitive due to which body movements affect its accuracy, or some devices only work on the left arm are expected to restrain the growth of this market. Moreover, the need for continuous recalibration of the devices may be certain limiting factors of the Digital/Electrical Sphygmomanometer market growth.
Moreover, the impact of the COVID-19 pandemic was positive on the Digital/Electrical Sphygmomanometer market. COVID-19 outbreak extensively instigated increased use of Digital/Electrical Sphygmomanometer as it was used as an essential procedure in events of complications to rule out issues associated with COVID-19. This resulted in the increased demand for Digital/Electrical Sphygmomanometer during the pandemic. Therefore, the market for Digital/Electrical Sphygmomanometer had a positive growth rate during the COVID-19 pandemic.
Digital/Electrical Sphygmomanometer Market Segment Analysis:
Digital/Electrical Sphygmomanometer Market By Product Type (Upper Arm, Wrist Type), By Technology (Full-Automatic, Semi-Automatic), By Portability (Portable, Non-Portable), By End-User (Hospitals and Clinics, Ambulatory Care Centers, Home Care Settings, Others), and By Geography (North America, Europe, Asia-Pacific, And Rest of the World)
In the Product Type segment of the Digital/Electrical Sphygmomanometer market, the Portable Digital/Electrical Sphygmomanometer is estimated to hold a significant share in the Digital/Electrical Sphygmomanometer market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices. The rapid growth of this product segment can be attributed to the growing demand for early and accurate diagnosis and leads to the high adoption of these devices. Further, the growing adoption of Portable Digital/Electrical Sphygmomanometer by hospitals and the in-home healthcare sector around the world is also driving the market growth.
Since the beginning of the COVID-19 pandemic, the demand for portable Digital/Electrical Sphygmomanometer has been on the rise. Portable Digital/Electrical Sphygmomanometer provides high-quality tracings that can be achieved both at home and in the office setting. Also, Portable Digital/Electrical Sphygmomanometer are an important contribution to epidemiologic and clinical studies that require frequent measures of a more broad range of cardiology function parameters. Therefore, the growing demand for disease diagnosis and treatment benefits the segment growth of the Digital/Electrical Sphygmomanometer market. Hence, their reliability has constantly increased with time and advancements in the newer generation of devices. Therefore, considering the advantages associated with Portable Digital/Electrical Sphygmomanometer, this category is expected to generate significant revenue share eventually contributing to the overall growth of the global Digital/Electrical Sphygmomanometer market during the forecast period.
North America is expected to dominate the overall Digital/Electrical Sphygmomanometer Market:
Among all the regions, North America is expected to account for the largest share in the global Digital/Electrical Sphygmomanometer market. Factors such as the high risk of blood pressure and hypertension among the population, technological advancement in product development, and increased product launches are expected to aid in the growth of the North America Digital/Electrical Sphygmomanometer Market in this region.
As per the data provided by the Centers for Disease Control and Prevention, as of 2022, High blood pressure, high blood cholesterol, and smoking are key risk factors for heart disease. About half of people in the United States (47%) have at least one of these three risk factors.
Additionally, according to the data of the American Heart Association 2022, in the year 2018, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths in the US, attributable to high blood pressure (11.0%), Heart failure (9.6%), diseases of the arteries (2.9%), and others (17.4%).
Therefore, the rising risk factors of blood-related disorders in the country would result in the rising demand for treatments that make use of Digital/Electrical Sphygmomanometer, which in turn would provide a conducive growth environment for the United States Digital/Electrical Sphygmomanometer market as well as the North American region.
Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Digital/Electrical Sphygmomanometer. For instance, in march 2022, Qardio, Inc. announced the US Food and Drug Administration (FDA) 510k clearance for its QardioCore ambulatory ECG device. QardioCore extended Qardio's remote patient monitoring platform from primary care and hypertension monitoring to acute care and cardiology, in a single, intuitive platform.
The product launches in the local markets correlate to a significant reduction in costs thereby making them affordable for end-users which in turn drives the product demand in the market. Therefore, the interplay of various factors such as the presence of a large patient population, as well as new product launches in the region is expected to boost the North America Digital/Electrical Sphygmomanometer market during the forecast period.
Digital/Electrical Sphygmomanometer Market Key Players:
Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.
Recent Developmental Activities in the Digital/Electrical Sphygmomanometer Market:
In February 2022, Abbott announced the US Food and Drug Administration (FDA) approval of an expanded indication for its CardioMEMS(TM) HF System to support the care of more people living with heart failure. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.
In November 2020, Blipcare developed a Wi-Fi blood pressure monitor and announced the availability of its new cellular blood pressure monitor, the Blip BP 800.
Key Takeaways from the Digital/Electrical Sphygmomanometer Market Report Study
Target Audience who can be benefited from this Digital/Electrical Sphygmomanometer Market Report Study
Frequently Asked Questions for Digital/Electrical Sphygmomanometer Market:
Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). These devices are of three types mainly mercury sphygmomanometers, an aneroid sphygmomanometer, and electronic/digital sphygmomanometer. A digital sphygmomanometer works on an oscillometric principle in which the blood pressure in an artery is measured by sensing arterial wall vibrations.
The Global Digital/Electrical Sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57%% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030.
The Digital/Electrical Sphygmomanometer market is witnessing a positive market growth owing to the factors such as the rising cases of blood-related disorders like high blood pressure and hypertension, rapid evolution and technological advancements in product development, increasing aging population who are more prone to hypertension risk.
Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.
North America is expected to hold the highest share in the revenue in the Digital/Electrical Sphygmomanometer market during the forecast period. Factors such as the high risk of blood pressure and hypertension among the population, technological advancement in product development, and increased product launches are also expected to aid in the Digital/Electrical Sphygmomanometer market growth in this region.